Factors contributing to mortality in paracetamol-induced hepatic failure

Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ 1981-01, Vol.282 (6259), p.199-201
Hauptverfasser: Canalese, J, Gimson, A E, Davis, M, Williams, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 201
container_issue 6259
container_start_page 199
container_title BMJ
container_volume 282
creator Canalese, J
Gimson, A E
Davis, M
Williams, R
description Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to the local hospital early enough (within 12 hours) to benefit from protective agents, and only three of these were treated. Treatment was delayed in two patients while the results of plasma paracetamol concentrations were awaited. Signs of grade 3 hepatic encephalopathy were never found until 72 hours after the overdose, and sudden deterioration in consciousness at an earlier stage was due either to the sedative effects of drugs or to hypoglycaemia, which in one patient went unrecognised for 24 hours. A rapid deterioration in prothrombin time, which became prolonged by at least 25 seconds at 48 hours, preceded the onset of grade 3 encephalopathy, and this is the time at which transfer should be arranged to avoid the danger of brain-stem coning. This occurred more rapidly in those transferred at a later stage of their illness.
doi_str_mv 10.1136/bmj.282.6259.199
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1503932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>29500304</jstor_id><sourcerecordid>29500304</sourcerecordid><originalsourceid>FETCH-LOGICAL-b540t-7ea2443222b60b3013e1ccb3a2e199c495e483b8922adf7c94ef8192c3993dfc3</originalsourceid><addsrcrecordid>eNqFkMFLHDEchUOp2GX13kthwGOZNckvk0wuhbK4KohCqV5DJpPRbGcm2yRT6n9vll1WPXnK4Xt5efkQ-krwghDg582wXtCaLjit5IJI-QnNCON1WdUAn9EMUy5KzCl8QacxrjHGFEQtOTtGx1wIKZmcoauVNsmHWBg_puCaKbnxsUi-GHxIunfpuXBjsdFBG5v04PvSje1kbFs82Y1OzhSddv0U7Ak66nQf7en-nKP71cXv5VV5c3d5vfx5UzYVw6kUVlPGgFLacNwAJmCJMQ1oavMPDJOVZTU0taRUt50wktmuJpIakBLazsAc_dj1bqZmsK2xebbu1Sa4QYdn5bVT78nontSj_6dIhUECzQVn-4Lg_042JrX2UxjzZkWE4MCxyMk5wruUCT7GYLvDCwSrrX2V7atsX23tq7w9X_n2dtnhwt71K1_HbPyAqawwBswyL3fcxWT_H7gOf3IFiErdPixVfcsY-7UCtcr577v8dsmH614A6XKnhg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776360750</pqid></control><display><type>article</type><title>Factors contributing to mortality in paracetamol-induced hepatic failure</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>PubMed Central</source><creator>Canalese, J ; Gimson, A E ; Davis, M ; Williams, R</creator><creatorcontrib>Canalese, J ; Gimson, A E ; Davis, M ; Williams, R</creatorcontrib><description>Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to the local hospital early enough (within 12 hours) to benefit from protective agents, and only three of these were treated. Treatment was delayed in two patients while the results of plasma paracetamol concentrations were awaited. Signs of grade 3 hepatic encephalopathy were never found until 72 hours after the overdose, and sudden deterioration in consciousness at an earlier stage was due either to the sedative effects of drugs or to hypoglycaemia, which in one patient went unrecognised for 24 hours. A rapid deterioration in prothrombin time, which became prolonged by at least 25 seconds at 48 hours, preceded the onset of grade 3 encephalopathy, and this is the time at which transfer should be arranged to avoid the danger of brain-stem coning. This occurred more rapidly in those transferred at a later stage of their illness.</description><identifier>ISSN: 0267-0623</identifier><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>DOI: 10.1136/bmj.282.6259.199</identifier><identifier>PMID: 6779949</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Acetaminophen - poisoning ; Adult ; Blood plasma ; Chemical and Drug Induced Liver Injury ; Critical Care ; Encephalopathies ; Female ; Grade 3 ; Hepatic encephalopathy ; Hepatic Encephalopathy - chemically induced ; Humans ; Liver ; Liver Diseases - mortality ; Liver Diseases - therapy ; Liver failure ; Male ; Mortality ; Necrosis ; Occasional Review ; Overdose ; Protective agents ; Retrospective Studies ; Time Factors</subject><ispartof>BMJ, 1981-01, Vol.282 (6259), p.199-201</ispartof><rights>Copyright 1981 British Medical Journal</rights><rights>Copyright BMJ Publishing Group LTD Jan 17, 1981</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b540t-7ea2443222b60b3013e1ccb3a2e199c495e483b8922adf7c94ef8192c3993dfc3</citedby><cites>FETCH-LOGICAL-b540t-7ea2443222b60b3013e1ccb3a2e199c495e483b8922adf7c94ef8192c3993dfc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/29500304$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/29500304$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,803,885,27922,27923,53789,53791,58015,58248</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6779949$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Canalese, J</creatorcontrib><creatorcontrib>Gimson, A E</creatorcontrib><creatorcontrib>Davis, M</creatorcontrib><creatorcontrib>Williams, R</creatorcontrib><title>Factors contributing to mortality in paracetamol-induced hepatic failure</title><title>BMJ</title><addtitle>Br Med J (Clin Res Ed)</addtitle><description>Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to the local hospital early enough (within 12 hours) to benefit from protective agents, and only three of these were treated. Treatment was delayed in two patients while the results of plasma paracetamol concentrations were awaited. Signs of grade 3 hepatic encephalopathy were never found until 72 hours after the overdose, and sudden deterioration in consciousness at an earlier stage was due either to the sedative effects of drugs or to hypoglycaemia, which in one patient went unrecognised for 24 hours. A rapid deterioration in prothrombin time, which became prolonged by at least 25 seconds at 48 hours, preceded the onset of grade 3 encephalopathy, and this is the time at which transfer should be arranged to avoid the danger of brain-stem coning. This occurred more rapidly in those transferred at a later stage of their illness.</description><subject>Acetaminophen - poisoning</subject><subject>Adult</subject><subject>Blood plasma</subject><subject>Chemical and Drug Induced Liver Injury</subject><subject>Critical Care</subject><subject>Encephalopathies</subject><subject>Female</subject><subject>Grade 3</subject><subject>Hepatic encephalopathy</subject><subject>Hepatic Encephalopathy - chemically induced</subject><subject>Humans</subject><subject>Liver</subject><subject>Liver Diseases - mortality</subject><subject>Liver Diseases - therapy</subject><subject>Liver failure</subject><subject>Male</subject><subject>Mortality</subject><subject>Necrosis</subject><subject>Occasional Review</subject><subject>Overdose</subject><subject>Protective agents</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><issn>0267-0623</issn><issn>0959-8138</issn><issn>1468-5833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkMFLHDEchUOp2GX13kthwGOZNckvk0wuhbK4KohCqV5DJpPRbGcm2yRT6n9vll1WPXnK4Xt5efkQ-krwghDg582wXtCaLjit5IJI-QnNCON1WdUAn9EMUy5KzCl8QacxrjHGFEQtOTtGx1wIKZmcoauVNsmHWBg_puCaKbnxsUi-GHxIunfpuXBjsdFBG5v04PvSje1kbFs82Y1OzhSddv0U7Ak66nQf7en-nKP71cXv5VV5c3d5vfx5UzYVw6kUVlPGgFLacNwAJmCJMQ1oavMPDJOVZTU0taRUt50wktmuJpIakBLazsAc_dj1bqZmsK2xebbu1Sa4QYdn5bVT78nontSj_6dIhUECzQVn-4Lg_042JrX2UxjzZkWE4MCxyMk5wruUCT7GYLvDCwSrrX2V7atsX23tq7w9X_n2dtnhwt71K1_HbPyAqawwBswyL3fcxWT_H7gOf3IFiErdPixVfcsY-7UCtcr577v8dsmH614A6XKnhg</recordid><startdate>19810117</startdate><enddate>19810117</enddate><creator>Canalese, J</creator><creator>Gimson, A E</creator><creator>Davis, M</creator><creator>Williams, R</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>19810117</creationdate><title>Factors contributing to mortality in paracetamol-induced hepatic failure</title><author>Canalese, J ; Gimson, A E ; Davis, M ; Williams, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b540t-7ea2443222b60b3013e1ccb3a2e199c495e483b8922adf7c94ef8192c3993dfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Acetaminophen - poisoning</topic><topic>Adult</topic><topic>Blood plasma</topic><topic>Chemical and Drug Induced Liver Injury</topic><topic>Critical Care</topic><topic>Encephalopathies</topic><topic>Female</topic><topic>Grade 3</topic><topic>Hepatic encephalopathy</topic><topic>Hepatic Encephalopathy - chemically induced</topic><topic>Humans</topic><topic>Liver</topic><topic>Liver Diseases - mortality</topic><topic>Liver Diseases - therapy</topic><topic>Liver failure</topic><topic>Male</topic><topic>Mortality</topic><topic>Necrosis</topic><topic>Occasional Review</topic><topic>Overdose</topic><topic>Protective agents</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Canalese, J</creatorcontrib><creatorcontrib>Gimson, A E</creatorcontrib><creatorcontrib>Davis, M</creatorcontrib><creatorcontrib>Williams, R</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Canalese, J</au><au>Gimson, A E</au><au>Davis, M</au><au>Williams, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors contributing to mortality in paracetamol-induced hepatic failure</atitle><jtitle>BMJ</jtitle><addtitle>Br Med J (Clin Res Ed)</addtitle><date>1981-01-17</date><risdate>1981</risdate><volume>282</volume><issue>6259</issue><spage>199</spage><epage>201</epage><pages>199-201</pages><issn>0267-0623</issn><issn>0959-8138</issn><eissn>1468-5833</eissn><abstract>Fifty patients with fulminant hepatic failure from paracetamol overdose were reviewed retrospectively to determine whether there had been any avoidable delays in treatment with protective agents, or other preventable factors which could contribute to the high mortality. Only nine were admitted to the local hospital early enough (within 12 hours) to benefit from protective agents, and only three of these were treated. Treatment was delayed in two patients while the results of plasma paracetamol concentrations were awaited. Signs of grade 3 hepatic encephalopathy were never found until 72 hours after the overdose, and sudden deterioration in consciousness at an earlier stage was due either to the sedative effects of drugs or to hypoglycaemia, which in one patient went unrecognised for 24 hours. A rapid deterioration in prothrombin time, which became prolonged by at least 25 seconds at 48 hours, preceded the onset of grade 3 encephalopathy, and this is the time at which transfer should be arranged to avoid the danger of brain-stem coning. This occurred more rapidly in those transferred at a later stage of their illness.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>6779949</pmid><doi>10.1136/bmj.282.6259.199</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0267-0623
ispartof BMJ, 1981-01, Vol.282 (6259), p.199-201
issn 0267-0623
0959-8138
1468-5833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1503932
source MEDLINE; JSTOR Archive Collection A-Z Listing; PubMed Central
subjects Acetaminophen - poisoning
Adult
Blood plasma
Chemical and Drug Induced Liver Injury
Critical Care
Encephalopathies
Female
Grade 3
Hepatic encephalopathy
Hepatic Encephalopathy - chemically induced
Humans
Liver
Liver Diseases - mortality
Liver Diseases - therapy
Liver failure
Male
Mortality
Necrosis
Occasional Review
Overdose
Protective agents
Retrospective Studies
Time Factors
title Factors contributing to mortality in paracetamol-induced hepatic failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20contributing%20to%20mortality%20in%20paracetamol-induced%20hepatic%20failure&rft.jtitle=BMJ&rft.au=Canalese,%20J&rft.date=1981-01-17&rft.volume=282&rft.issue=6259&rft.spage=199&rft.epage=201&rft.pages=199-201&rft.issn=0267-0623&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.282.6259.199&rft_dat=%3Cjstor_pubme%3E29500304%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776360750&rft_id=info:pmid/6779949&rft_jstor_id=29500304&rfr_iscdi=true